Drug: Pertyze (pancrelipase)

Manufacturer: Digestive Care, Inc.

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of exocrine pancreatic insufficiency in adult and pediatric patients

Disease: exocrine pancreatic insufficiency

Therapeutic Area: Gastroenterology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: pertyze.com